A higher metabolic rate translates into increased flexibility in how the body metabolizes fats and carbs, which can assist type 2 diabetics and obese individuals in managing long-term health
The Australian and New Zealand College of Anaesthetists (ANZCA) and peak diabetes, obesity and gastroenterological bodies have updated recommendations, frequently asked questions (FAQs) and patient information for clinicians when talking to patients using GLP-1/GIP receptor agonists
FDA-approved GLP-1 medications for weight management are indicated for adults with a BMI of 30 or greater, or a BMI of 27 or greater with at least one weight-related health condition
Retatrutide vs Tirzepatide: Whats the Difference
That framing matters enormously for insurance coverage, for public health budgets, and for whether the people who need them most will ever actually have access to them
A comprehensive meta-analysis of observational cohort studies by Celsa et al